ELUTIA INC (ELUT)
(Delayed Data from NSDQ)
$1.97 USD
-0.07 (-3.43%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $2.02 +0.05 (2.54%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth D Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, Elutia Inc. has a market cap of $83.88M, which represents its share price of $2.04 multiplied by its outstanding shares number of 41.12M. As a small-cap company, ELUT's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ELUT 1.97 -0.07(-3.43%)
Will ELUT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ELUT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ELUT
Are Medical Stocks Lagging ELUTIA INC (ELUT) This Year?
ELUT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for ELUT
Dr. Michelle LeRoux Williams Earns Washington Business Journal's Medical Device Innovator Award ...
Elutia to Report Second Quarter 2025 Financial Results on Thursday, August 14, 2025 | ELUT ...
New Evidence Supports the Value of Elutia's Antibiotic-Eluting Platform for Implantable Devices ...
Elutia announces publication of new study on CIED biologic envelope
Aziyo Biologics Holds Annual Stockholders Meeting